153 related articles for article (PubMed ID: 12843220)
1. SPECT semiquantitative analysis of adrenocortical (131)I-6 beta iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma.
La Cava G; Imperiale A; Olianti C; Gheri GR; Ladu C; Mannelli M; Pupi A
J Nucl Med; 2003 Jul; 44(7):1057-64. PubMed ID: 12843220
[TBL] [Abstract][Full Text] [Related]
2. Tomographic evaluation of [131I] 6beta-iodomethyl-norcholesterol standardised uptake trend in clinically silent monolateral and bilateral adrenocortical incidentalomas.
Imperiale A; Olianti C; Mannelli M; La Cava G; Pupi A
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):287-96. PubMed ID: 16172575
[TBL] [Abstract][Full Text] [Related]
3. Application of adrenal maximum standardized uptake value to
Nakajo M; Jinguji M; Tani A; Yoshiura T
Eur J Radiol; 2020 Dec; 133():109397. PubMed ID: 33190101
[TBL] [Abstract][Full Text] [Related]
4. The relationship of adrenal iodomethylnorcholesterol uptake to indices of adrenal cortical function in Cushing's syndrome.
Gross MD; Valk TW; Freitas JE; Swanson DP; Schteingart DE; Beierwaltes WH
J Clin Endocrinol Metab; 1981 Jun; 52(6):1062-6. PubMed ID: 6262361
[TBL] [Abstract][Full Text] [Related]
5. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
[TBL] [Abstract][Full Text] [Related]
6. [Cushing with transition from pituitary to adrenal origin. Study with SPECT scintigraphy of the adrenal cortex with norcholesterol-I 131 in a case].
Araya V; Jofré J; Hidalgo P; Massardo T; Amat J; Pumarino H
Rev Med Chil; 1998 Sep; 126(9):1103-7. PubMed ID: 9922515
[TBL] [Abstract][Full Text] [Related]
7. 131I-6beta-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results.
Yen RF; Wu VC; Liu KL; Cheng MF; Wu YW; Chueh SC; Lin WC; Wu KD; Tzen KY; Lu CC;
J Nucl Med; 2009 Oct; 50(10):1631-7. PubMed ID: 19759122
[TBL] [Abstract][Full Text] [Related]
8. Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas.
Katabami T; Ishii S; Obi R; Asai S; Tanaka Y
Endocr J; 2016 Dec; 63(12):1123-1132. PubMed ID: 27616151
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses.
Maurea S; Klain M; Mainolfi C; Ziviello M; Salvatore M
J Nucl Med; 2001 Jun; 42(6):884-92. PubMed ID: 11390552
[TBL] [Abstract][Full Text] [Related]
10. Scintigraphic diagnosis of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
Dominguez-Gadea L; Diez L; Piedrola-Maroto G; Crespo A
Nucl Med Commun; 1996 Jan; 17(1):29-32. PubMed ID: 8692469
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
[TBL] [Abstract][Full Text] [Related]
12. Hormonal, Radiological, NP-59 Scintigraphy, and Pathological Correlations in Patients With Cushing's Syndrome Due to Primary Pigmented Nodular Adrenocortical Disease (PPNAD).
Vezzosi D; Tenenbaum F; Cazabat L; Tissier F; Bienvenu M; Carrasco CA; Laloi-Michelin M; Barrande G; Lefebvre H; Hiéronimus S; Tabarin A; Bertagna X; Legmann P; Vantyghem MC; Bertherat J
J Clin Endocrinol Metab; 2015 Nov; 100(11):4332-8. PubMed ID: 26390100
[TBL] [Abstract][Full Text] [Related]
13. Adrenal cortical imaging with I-131 NP-59 SPECT-CT.
Wong KK; Komissarova M; Avram AM; Fig LM; Gross MD
Clin Nucl Med; 2010 Nov; 35(11):865-9. PubMed ID: 20940544
[TBL] [Abstract][Full Text] [Related]
14. [Nuclear medicine methods for the diagnosis of adrenal tumors].
Gregianin M; Bui F; Varotto L; Zucchetta P; Macri C
Minerva Endocrinol; 1995 Mar; 20(1):27-38. PubMed ID: 7651280
[TBL] [Abstract][Full Text] [Related]
15. [ACTH-independent macronodular adrenal hyperplasia and subclinical Cushing's syndrome].
Cortés-Berdonces M; Avilés-Pérez MD; García-Martín A; Muñoz-Torres M
Med Clin (Barc); 2012 Feb; 138(2):89-90. PubMed ID: 21703642
[No Abstract] [Full Text] [Related]
16. The role of adrenocortical scintigraphy in the evaluation of unilateral incidentally discovered adrenal and juxtaadrenal masses.
Nakajo M; Nakabeppu Y; Yonekura R; Iwashita S; Goto T
Ann Nucl Med; 1993 Aug; 7(3):157-66. PubMed ID: 8217490
[TBL] [Abstract][Full Text] [Related]
17. Quantitative imaging characterization of hypersecreting or nonhypersecreting adrenal adenomas: comparison between iodine-131 norcholesterol uptake and magnetic resonance signal intensity ratios.
Maurea S; Imbriaco M; Mollica C; Pace L; Salvatore M
Nucl Med Commun; 2011 Jun; 32(6):535-41. PubMed ID: 21448089
[TBL] [Abstract][Full Text] [Related]
18. The relationship of serum lipids to adrenal-gland uptake of 6 beta-[131I]iodomethyl-19-norcholesterol in Cushing's syndrome.
Valk TW; Gross MD; Freitas JE; Swanson DP; Schteingart DE; Beierwaltes WH
J Nucl Med; 1980 Nov; 21(11):1069-72. PubMed ID: 7431105
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic dilemma of small incidentally discovered adrenal masses: role for 131I-6beta-iodomethyl-norcholesterol scintigraphy.
Kloos RT; Gross MD; Shapiro B; Francis IR; Korobkin M; Thompson NW
World J Surg; 1997 Jan; 21(1):36-40. PubMed ID: 8943175
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of hormonal function in a series of incidentally discovered adrenal masses.
Bondanelli M; Campo M; Trasforini G; Ambrosio MR; Zatelli MC; Franceschetti P; Valentini A; Pansini R; degli Uberti EC
Metabolism; 1997 Jan; 46(1):107-13. PubMed ID: 9005978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
